Wu Lu, Li Mei, Liu Dingyi, Jiang Ming, Liu Yanyang, Li Zhixi, Wang Xia, Yu Yang, Luo Feng
Department of Medical Oncology, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Department of Oncology, Chengdu Seventh People's Hospital, Chengdu, Sichuan 610041, P.R. China.
Oncol Lett. 2014 Aug;8(2):753-757. doi: 10.3892/ol.2014.2180. Epub 2014 May 26.
In China, the incidence of nasopharyngeal carcinoma (NPC) and tuberculosis remains high. Additionally, there has been a marked increase in the prevalence of gout. In recent years, there has been an increase in the number of co-existing diseases. To the best of our knowledge, there have been no previous cases reported in the literature with regard to patients suffering from NPC complicated with pulmonary tuberculosis and gout. The present study describes the case of a 59-year-old male with this condition. The patient received a combination of anti-tumor, anti-tuberculosis and anti-gout therapies, and experienced no severe adverse reactions during treatment. At present, the patient's Eastern Cooperative Oncology Group performance status is good, there has been no local recurrence or distant metastasis of the NPC, and the pulmonary tuberculosis and gout are well controlled. The aim of this study was to provide insight into the treatment of patients suffering from co-existing conditions.
在中国,鼻咽癌(NPC)和结核病的发病率仍然很高。此外,痛风的患病率显著上升。近年来,合并疾病的数量有所增加。据我们所知,此前文献中尚未报道过鼻咽癌合并肺结核和痛风的患者病例。本研究描述了一名患有这种疾病的59岁男性的病例。该患者接受了抗肿瘤、抗结核和抗痛风联合治疗,治疗期间未出现严重不良反应。目前,该患者的东部肿瘤协作组体能状态良好,鼻咽癌无局部复发或远处转移,肺结核和痛风得到良好控制。本研究的目的是为患有合并疾病的患者的治疗提供见解。